Teletrix, a company specializing in radiation training tools, has transitioned from a research and development license to a commercial license for its augmented reality, or AR, platform that simulates ionizing radiation. This advanced platform, known as VIZRAD AR, was developed using technologies licensed from the Department of Energy’s Oak Ridge National Laboratory and allows users to interact with virtual radiological environments in real time.
The Monell Chemical Senses Center and A*STAR Singapore Institute of Food and Biotechnology Innovation are about to sign a Memorandum of Understanding to promote academic cooperation and exchange in education and research, with the vision of creating a healthier world by unlocking the mysteries of our senses.
OnsiteGene Inc. launches XDive®, the first 5-minute real-time PCR instrument, achieving 40 thermal cycles with fluorescent imaging in 5 minutes. With FDA EUA for COVID-19, XDive offers efficiency, processing 16 samples and 64 targets per run. OnsiteGene seeks global distributors and collaborators.
Ms. Supamas Isarabhakdi, Minister of Higher Education, Science, Research and Innovation, attended the launching of the innovative Microalbuminuria Rapid Test developed by a team of experts and researchers from the Faculty of Medicine, Chulalongkorn University. The test, which is convenient and easy to use and offers high accuracy, allows users to self-screen for kidney damage, giving it commercial potential in order to enhance Thailand’s healthcare system. It is expected for distribution in mid-2024.
To date, nine medical device developers participating in the RADx® Tech Independent Test Assessment Program have received emergency use authorization for at-home and point-of care test products that simultaneously detect COVID-19 and flu A/B.
Babies with medical devices such as g-tubes, j-tubes, PICC lines, ports, and more often face challenges in finding suitable clothing that accommodates their needs.
CLEVELAND, OH and TITUSVILLE, FL: Cleveland Clinic and Parrish Medical Center, a Parrish Healthcare integrated care partner, jointly announced that Parrish Medical Center has become a member of Cleveland Clinic Connected.
Avails Medical, Inc., a leader in the development of rapid, automated and fully electrical antibiotic susceptibility testing (AST) technologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking eQUANTTM system.
Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and a certified Oxford Nanopore Technologies' laboratory, launches a proprietary Targeted DNA Methylation Sequencing Service for researchers and clinical service providers.
Koning Health, a pioneer in advanced medical imaging technology, is proud to announce the successful showcasing of the Koning Vera Breast CT at the prestigious Arab Health exhibition in Dubai.
Stuart Therapeutics, Inc. ("Stuart"), a clinical-stage biopharmaceutical company with candidate therapeutics in various phases of clinical development, today announced that it has appointed Jodi Luchs, MD to the position of Chief Medical Officer, and Don Stires to the position of Chief Financial Officer.
Harmonic Discovery (the "Company"), a precision pharmacology company focusing on developing next generation kinase inhibitors, today announced an exclusive licensing agreement of a novel small-molecule drug candidate for the treatment of FLT3 mutated acute myeloid leukemia (AML) from BioVentures (University of Arkansas for Medical Sciences) and UC San Francisco (UCSF).
The U.S. Food and Drug Administration has placed a purchase order (75F40123P00369) committing to an annual subscription of digiM I2S, a fully integrated image processing platform based on digiM's proprietary cloud technology.
Quiet Events®, a leader in Silent Disco events and rentals, announces an exciting new partnership with the Day By Day Project, a pioneer in the innovative Memory Disco™ program.
FDA's De Novo approval of BrainSee represents a major advancement in Alzheimer's diagnostics. Utilizing cutting-edge image processing and medical AI, BrainSee establishes a new standard for predicting progression from amnestic mild cognitive impairment (aMCI) to Alzheimer's dementia. This breakthrough is a significant step in proactive brain health management, offering a fully non-invasive, convenient, and globally accessible screening solution, to be prioritized before other tests or treatments.
The AccuSignal™ Nuclease ELISA Kit is designed to detect any Serratia marcescens endonuclease, such as Benzonase®, DENARASE®, and Turbonuclease, to evaluate manufacturing processes for biological therapeutics, gene therapy vectors, vaccine preparations, and more.